当前位置：
X-MOL 学术
›
Eur. Heart J. Cardiovasc. Pharmacother.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
De-escalation of antiplatelets after percutaneous coronary intervention: a Bayesian network meta-analysis of various de-escalation strategies
European Heart Journal-Cardiovascular Pharmacotherapy ( IF 5.3 ) Pub Date : 2020-04-09 , DOI: 10.1093/ehjcvp/pvaa025 Safi U Khan 1 , Muhammad Zia Khan 1 , Muhammad Shahzeb Khan 2 , Ahmed Mahmood 3 , Ankur Kalra 4 , Edo Kaluski 5 , Erin D Michos 6 , Mohamad Alkhouli 7
European Heart Journal-Cardiovascular Pharmacotherapy ( IF 5.3 ) Pub Date : 2020-04-09 , DOI: 10.1093/ehjcvp/pvaa025 Safi U Khan 1 , Muhammad Zia Khan 1 , Muhammad Shahzeb Khan 2 , Ahmed Mahmood 3 , Ankur Kalra 4 , Edo Kaluski 5 , Erin D Michos 6 , Mohamad Alkhouli 7
Affiliation
To compare early de-escalation of dual antiplatelet therapy (DAPT) (1–3 months) to monotherapy with either P2Y12 inhibitor or aspirin vs. 12 months DAPT after percutaneous coronary intervention (PCI) with drug-eluting stent (DES).
中文翻译：
经皮冠状动脉介入治疗后抗血小板降级：各种降级策略的贝叶斯网络荟萃分析
比较双重抗血小板治疗 (DAPT) (1-3 个月) 与 P2Y12 抑制剂或阿司匹林单药治疗与药物洗脱支架 (DES) 经皮冠状动脉介入治疗 (PCI) 后 12 个月 DAPT 的早期降级。
更新日期：2020-04-09
中文翻译：
经皮冠状动脉介入治疗后抗血小板降级：各种降级策略的贝叶斯网络荟萃分析
比较双重抗血小板治疗 (DAPT) (1-3 个月) 与 P2Y12 抑制剂或阿司匹林单药治疗与药物洗脱支架 (DES) 经皮冠状动脉介入治疗 (PCI) 后 12 个月 DAPT 的早期降级。
京公网安备 11010802027423号